Sisram Med Successfully Listed on Main Board of SEHK

September 20, 2017, 5:34 am

≫ Next: Net Proceeds of approximately HK$877.2 Million from Global Offering; Sisram Med Trading Debut on SEHK on 19 September 2017

≪ Previous: Hitachi Hosts "Hitachi Social Innovation Forum 2017 TOKYO"

The Management of Fosun Intl, Fosun Pharma and Sisram Med on the listing ceremony

Mr Lior M Dayan, CEO of Sisram (Right) and Mr Yi Liu, Chairman and Executive Director of Sisram, (Left) hit the gong to announce the start of trading

HONG KONG, Sep 20, 2017 - (ACN Newswire) - The leading global provider of energy-based medical aesthetic treatment systems - Sisram Medical Ltd ("Sisram Med" or the "Company"; stock code: 1696.HK), was officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ( "SEHK") on 19 September.

The Management of both Fosun International Limited ("Fosun Intl", together with its subsidiaries, "Fosun Group", stock code: 656.HK) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 2196.HK), the controlling shareholders of Sisram Med, attended the listing ceremony to show their support on the Company's listing.

Mr Guangchang Guo, the Chairman of Fosun Intl, said, "Fosun Group aims to be a technology-led enterprise, while Israel is a world-famous state of innovation. We are pleased to work with this outstanding Israeli technology company and have it successfully listed on the Main Board of SEHK. Being customer-oriented focus, Sisram Med is able to catch up with market demands, and together with its strong R&D strength, the Company is in line with Fosun Group's development strategy. We believe that the greater transparency in operation Sisram Med has after listing will further aid its business growth and development in China. Besides, China and Israel are two economic entities strongly complementary with each other. Under the "Belt and Road" initiative, we hope Sisram Med could become an exemplar of Chinese-Israeli cooperation in future.

Mr Qiyu Chen, Co-president of Fosun Intl and Chairman of Fosun Pharma, said "Being the first Israeli company being listed in Hong Kong, Sisram Med needs to undergo a get-to-know process from the market and investors. As the Company's major shareholder, we are optimistic about its industry prospects, sustainable R&D strength and profitability. We have full confidence in Sisram Med's future development. "

Mr. Yi Liu, Chairman and Executive Director of Sisram Med, said on the listing ceremony: "The listing of Sisram Med today marks an important milestone for our Company to enter into the international capital market. Sisram Med aims to become the largest global provider of energy-based medical aesthetic treatment systems. In the future, we will keep pace on meeting the evolving market demands with innovative products driven by our reinforcing research and development strength. Furthermore, we will continue to increase our market share, and particularly our position as the largest provider in the PRC through the cooperation and support with our parent company Fosun Pharma ."

About Sisram Medical Ltd
Sisram Medical Ltd (stock code: 1696.HK) is a leading global provider of energy-based medical aesthetic treatment systems, with comprehensive in-house capability to design, develop and produce such systems, which often feature the Company's innovative and proprietary technologies. "Alma" brand, as well as the brands of many of the Company's products such as "Soprano", "Harmony", "Accent" and "FemiLift", are widely recognized and well regarded among treatment providers and treatment recipients internationally. The Company has also been the largest provider of energy-based medical aesthetic treatment systems in the PRC market and one of the leaders in the medical aesthetic treatment system market globally, in terms of revenue in 2016, according to the Medical Insight Report. The company sells its treatment systems in approximately 80 countries and jurisdictions worldwide. Sisram Med, incorporated in 2013 in Israel, is a non-wholly owned subsidiary of Fosun Pharma. Fosun Pharma is a leading healthcare group in China with businesses covering the whole healthcare industry chain.

↧

Net Proceeds of approximately HK$877.2 Million from Global Offering; Sisram Med Trading Debut on SEHK on 19 September 2017

September 20, 2017, 5:57 am

≫ Next: First Half 2017 Breach Level Index Report: Identity Theft and Poor Internal Security Practices Take a Toll

≪ Previous: Sisram Med Successfully Listed on Main Board of SEHK

HONG KONG, Sep 20, 2017 - (ACN Newswire) - Sisram Medical Ltd ("Sisram Med" or the "Company"; stock code: 1696.HK), announced the allotment results of its global offering, which offers a total of 110,000,000 shares comprising of 88,000,000 new shares offered by the Company and 22,000,000 sale shares by a controlling shareholder, Magnificent View Investments Limited (the "Selling Shareholder"). The offer price was set at HK$8.88 per share. Assuming that the over-allotment option is not exercised, the net proceeds from the global offering to be received by the Company, after deduction of underwriting fees and commissions and estimated expenses payable in connection with the global offering, are estimated to be approximately HK$688.7 million; while those to be received by the Selling Shareholder, after deduction of underwriting fees and commissions payable, are estimated to be approximately HK$188.5 million.

The valid applications received pursuant to the Hong Kong public offering represented approximately 17.58 times of the total number of 11,000,000 Hong Kong offer shares initially available for subscription. Due to the over-subscription, a total number of 22,000,000 shares have been reallocated from the international offering to the Hong Kong public offering. As a result, a final number of 33,000,000 offer shares were allocated to the Hong Kong public offering, representing 30% of the global offering size before any exercise of the over-allotment option.

The international offering was also moderately over-subscribed. After reallocation, a final number of 77,000,000 offer shares were allocated to the placees and qualifying shareholders of Fosun International Limited under international offering, including the reserved shares offered under the preferential offering.

Sisram Med has entered into cornerstone investment agreements with Shanghai Free Trade Zone Phase I Equity Investment Fund Partnership Enterprise (Limited Partnership), Rise Huge Corporation Limited and Neo Derm Group Limited for the subscription of aggregate 25,296,800 offer shares, with respective offer shares of 13,175,600 shares, 8,783,600 shares and 3,337,600 shares, accounting for approximately 23.00% of the global offering size before any exercise of the over-allotment option.

China International Capital Corporation Hong Kong Securities Limited ("CICC") and Jefferies Hong Kong Limited (in alphabetical order) are the joint sponsors, and together with Fosun Hani Securities Limited are the joint global coordinators. The joint global coordinators, together with Haitong International Securities Company Limited, Huatai Financial Holdings (Hong Kong) Limited and CMB International Capital Limited (in relation to the international offering only) are the joint bookrunners and joint lead managers. CICC is the sole settlement agent and sole stabilizing manager.

Share trading of Sisram Med on the Main Board of the Hong Kong Stock Exchange Limited ("SEHK") was commenced on 19 September 2017 (Tuesday), with the stock code 1696 in board lots of 400 shares each.

About Sisram Medical Ltd
Sisram Medical Ltd (stock code: 1696.HK) is a leading global provider of energy-based medical aesthetic treatment systems, with comprehensive in-house capability to design, develop and produce such systems, which often feature the Company's innovative and proprietary technologies. "Alma" brand, as well as the brands of many of the Company's products such as "Soprano", "Harmony", "Accent" and "FemiLift", are widely recognized and well regarded among treatment providers and treatment recipients internationally. The Company has also been the largest provider of energy-based medical aesthetic treatment systems in the PRC market and one of the leaders in the medical aesthetic treatment system market globally, in terms of revenue in 2016, according to the Medical Insight Report. The company sells its treatment systems in approximately 80 countries and jurisdictions worldwide. Sisram Med, incorporated in 2013 in Israel, is a non-wholly owned subsidiary of Fosun Pharma. Fosun Pharma is a leading healthcare group in China with businesses covering the whole healthcare industry chain.

↧

First Half 2017 Breach Level Index Report: Identity Theft and Poor Internal Security Practices Take a Toll

September 19, 2017, 6:00 pm

≫ Next: Fujitsu Technology Facilitates Application of Combinatorial Optimization Methods to Real-World Problems

≪ Previous: Net Proceeds of approximately HK$877.2 Million from Global Offering; Sisram Med Trading Debut on SEHK on 19 September 2017

- 164% increase in stolen, lost or compromised records
- 103% increase in the number of breaches in the education industry
- 74% of data breach incidents were identity theft

AMSTERDAM, Sep 20, 2017 - (ACN Newswire) - Gemalto, the world leader in digital security, today released the latest findings of the Breach Level Index, a global database of public data breaches, revealing 918 data breaches led to 1.9 billion data records being compromised worldwide in the first half of 2017. Compared to the last six months of 2016, the number of lost, stolen or compromised records increased by a staggering 164%. A large portion came from the 22 largest data breaches, each involving more than one million compromised records. Of the 918 data breaches more than 500 (59% of all breaches) had an unknown or unaccounted number of compromised data records.

The Breach Level Index is a global database that tracks data breaches and measures their severity based on multiple dimensions, including the number of records compromised, the type of data, the source of the breach, how the data was used, and whether or not the data was encrypted. By assigning a severity score to each breach, the Breach Level Index provides a comparative list of breaches, distinguishing data breaches that are not serious versus those that are truly impactful.

According to the Breach Level Index, more than 9 billion data records have been exposed since 2013 when the index began benchmarking publicly disclosed data breaches. During the first six months of 2017, more than ten million records were compromised or exposed every day, or one hundred and twenty-two records every second, including medical, credit card and/or financial data or personally identifiable information. This is particularly concerning, since less than 1% of the stolen, lost or compromised data used encryption to render the information useless, a 4% drop compared to the last six months of 2016.

"IT consultant CGI and Oxford Economics recently issued a study, using data from the Breach Level Index and found that two-thirds of firms breached had their share price negatively impacted. Out of the 65 companies evaluated the breach cost shareholders over $52.40 billion," said Jason Hart, Vice President and Chief Technology Officer for Data Protection at Gemalto. "We can expect that number to grow significantly, especially as government regulations in the U.S., Europe and elsewhere enact laws to protect the privacy and data of their constituents by associating a monetary value to improperly securing data. Security is no longer a reactive measure but an expectation from companies and consumers."

Primary Sources of Data Breaches
Malicious outsiders made up the largest percentage of data breaches (74%), an increase of 23%. However, this source accounted for only 13% of all stolen, compromised or lost records. While malicious insider attacks only made up 8% of all breaches, the amount of records compromised was 20 million up from 500,000 an increase of over 4,114% from the previous six months.

Leading Types of Data Breaches
For the first six months of 2017, identity theft was the leading type of data breach in terms of incident, accounting for 74% of all data breaches, up 49% from the previous semester. The number of records compromised in identity theft breaches increased by 255%. The most significant shift was the nuisance category of data breaches representing 81% of all lost, stolen or compromised records. However, in terms of the number of incidents, nuisance type attacks were only slightly over 1% of all data breaches. The number of compromised records from account access attacks declined by 46%, after a significant spike in the 2016 BLI full year report.

Biggest Industries Affected by Data Breaches
Most of the industries the Breach Level Index tracks had more than a 100% increase in the number of compromised, stolen or lost records. Education witnessed one of the largest increases in breaches up by 103% with an increase of over 4,000% in the number of records. This is the result of a malicious insider attack compromising millions of records from one of China's largest comprehensive private educational companies. Healthcare had a relatively similar amount of breaches compared to the last six months of 2016, but stolen, lost or compromised records increased 423%. The U.K's National Health Service was one of the top five breaches in the first half with over 26 million compromised records. Financial services, government and entertainment were also industries that experienced a significant jump in the number of breached records, with entertainment breach incidents increasing 220% in the first six months of 2017.

Geographic Distribution of Data Breaches
North America still makes up the majority of all breaches and the number of compromised records, both above 86%. The number of breaches in North America increased by 23% with the number of records compromised skyrocketing by 201%. Traditionally, North America has always had the largest number of publicly disclosed breaches and associated record numbers, although this is poised to change in 2018 when global data privacy regulations like the European General Data Protection Regulation (GDPR) and Australia's Privacy Amendment (Notifiable Data Breaches) Act are enforced. Europe currently only had 49 reported data breaches (5% of all breaches), which is a 35% decline from the previous six months.

Related Resources:
- For a full summary of data breach incidents by industry, source, type and geographic region, download the First Half 2017 Breach Level Index Report http://www6.gemalto.com/breach-level-index-2017-h1-report-press-release
- Download the infographic here http://www6.gemalto.com/breach-level-index-2017-h1-infograph-press-release
- Visit the BLI website here http://www6.gemalto.com/breachlevelindex.com-press-release

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2016 annual revenues of EUR 3.1 billion and customers in over 180 countries. We bring trust to an increasingly connected world.

From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.

Gemalto's solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software - enabling our clients to deliver secure digital services for billions of individuals and things.

Our 15,000+ employees operate out of 112 offices, 43 personalization and data centers, and 30 research and software development centers located in 48 countries.

For more information visit www.gemalto.com, or follow @gemalto on Twitter.

Gemalto media contacts:

Philippe Benitez
Americas
+1 512 257 3869
philippe.benitez@gemalto.com

Kristel Teyras
Europe Middle East & Africa
+33 1 55 01 57 89
kristel.teyras@gemalto.com

Shintaro Suzuki
Asia Pacific
+65 6317 8266
shintaro.suzuki@gemalto.com

Press release (PDF): http://hugin.info/159293/R/2135273/817081.pdf
Picture: http://hugin.info/159293/R/2135273/817075.jpg

↧

Fujitsu Technology Facilitates Application of Combinatorial Optimization Methods to Real-World Problems

September 19, 2017, 7:30 pm

≫ Next: Fifth HKTDC Lifestyle Expo in Dubai Opens Monday

≪ Previous: First Half 2017 Breach Level Index Report: Identity Theft and Poor Internal Security Practices Take a Toll

Fig. 1: Process of applying the previous Digital Annealer to new types of problems

Fig. 2: New Digital Annealer featuring a status control circuit

Fig. 3: Example application to a molecular similarity comparison problem of about 50 atoms

Fig. 4: Example application to a diversified portfolio distribution optimization problem of 500 brands

Utilizing quantum-inspired computing technology, "Digital Annealer" applied to chemistry and finance

KAWASAKI, Japan, Sep 20, 2017 - (JCN Newswire) - Fujitsu Laboratories Ltd. today announced the development of technology to solve combinatorial optimization problems without setting complex parameters, using "Digital Annealer(1)" computational architecture, which is a versatile hardware accelerator for solving combinatorial optimization problems.

In computations using annealing methods, there is a tradeoff between the speed with which the method converges on a solution and the accuracy of the solution. For this reason, it was necessary to spend a few weeks, depending on circumstances, finding parameters that could deliver a solution of sufficient precision in a short time for each type of problem being handled.

Fujitsu Laboratories has now developed technology that makes it possible to find a solution of sufficient precision without the need to set complicated parameters by incorporating circuits that automatically control parameters based on the results of observations of the conditions within the Digital Annealer during performance. Fujitsu Laboratories has confirmed that this can reduce the preparation time before applying the Digital Annealer to a problem from about two weeks to less than a day, for problems such as comparing molecular similarities when searching for new materials or for investment portfolio optimization. With this technology, it has become possible to rapidly respond to the variety of combinatorial optimization problems that occur in the real world.

Fujitsu Laboratories plans to commercialize this technology in the first half of 2018, contributing to the creation of new business by applying it to a variety of fields, including chemistry, finance, energy, and distribution.

Background

The demand for the ability to choose the optimal solution from a number of various feasible solutions exists in numerous real-world fields. This sort of demand is classified as what are called combinatorial optimization problems. Combinatorial optimization problems can be difficult to solve quickly with existing processors, as the number of combinations would increase exponentially when the number of factors taken into consideration was increased.

Fujitsu Laboratories therefore developed the Digital Annealer to quickly solve such combinatorial optimization problems.

Issues

Annealing methods can be compared with a process in which a metal is heated to a high temperature, and then allowed to cool very gradually, causing the crystalline structure of the material to converge on an optimal state. By lowering the temperature, which in this example is controlled by the parameters, from a high point very gradually, the area in which to look for a solution is gradually narrowed down, finding the point of lowest energy. To rapidly locate this state, one can achieve an optimal degree of precision in the solution if the parameters are operated in a similar way to the gradual lowering of the temperature, but this increases computation time, whereas if the parameters are operated in a similar way to quickly lowering the temperature, the computation time becomes shorter, but the precision of the solution decreases, creating a tradeoff. The optimal values for the setting of these parameters, including both the initial values and the way they are changed during operation, varies for each type of problem for which these methods are applied.

When using annealing methods for problems for which they've never been applied before for the first time, such as comparing molecular similarity(2) and portfolio optimization(3), finding optimal parameter settings to begin with for each type of problem enables rapid computation for problems of that type thereafter. However, in order to find the optimal parameter settings to find a sufficiently precise solution in a short timeframe, annealing computation that changes the parameter settings could need to be repeated tens of thousands of times or more which could take a few weeks.

About the Newly Developed Technology

To expand the fields to which its Digital Annealer is applicable, Fujitsu Laboratories has now developed new technology to simplify use by eliminating the need to set complex parameters in advance.

With this technology, the multiple basic circuits within the Digital Annealer that handle optimization processing can be given simple initial parameters and operated in parallel. Moreover, status control circuits installed outside the basic circuits will observe the status during performance of each basic circuit at a set frequency, enabling an efficient search for an optimal solution by adjusting the parameters as appropriate.

http://www.acnnewswire.com/topimg/Low_FujitsuAnnealer92917Fig1.jpg
Fig. 1: Process of applying the previous Digital Annealer to new types of problems

http://www.acnnewswire.com/topimg/Low_FujitsuAnnealer92917Fig2.jpg
Fig. 2: New Digital Annealer featuring a status control circuit

Results

With this technology, users will be able to find an optimal solution with high probability without setting complex parameters in advance. For this reason, tuning tasks that previously had to be done manually, taking up significant time, have become unnecessary, and users can start operations using actual data, drawing out the full performance of the Digital Annealer in a short period of time, with the capability to shorten preparation times by somewhere between one tenth and one hundredth.

Now, using software developed by 1QBit (1QB Information Technologies Inc.)(4), Fujitsu Laboratories evaluated the effectiveness of this technology for problems on the scale of actual use cases in the chemistry and finance fields. The results showed that, for molecular similarity comparison problems of below 50 atoms (chemistry), and a portfolio optimization problem for 500 stocks (finance), this technology was confirmed to be able to shorten the preparation period required to find a solution of the necessary precision from the previous requirement of about two weeks to less than a day.

http://www.acnnewswire.com/topimg/Low_FujitsuAnnealer92917Fig3.jpg
Fig. 3: Example application to a molecular similarity comparison problem of about 50 atoms

http://www.acnnewswire.com/topimg/Low_FujitsuAnnealer92917Fig4.jpg
Fig. 4: Example application to a diversified portfolio distribution optimization problem of 500 brands

Future Plans

Fujitsu Laboratories aims to commercialize this technology in the first half of 2018, contributing to the creation of new business for customers in a variety of applicable fields, such as chemistry, finance, energy, and distribution.

(1) Digital Annealer
Fujitsu Laboratories Develops New Architecture that Rivals Quantum Computers in Utility (press release, October 20, 2016)
(2) Comparing molecular similarity
A problem of comparing and determining the structural and molecular similarity between two molecules.
(3) Portfolio optimization
A problem of determining the distribution of a diversified investment to minimize risk.
(4) 1QB Information Technologies Inc.

Fujitsu Laboratories and 1Qbit began collaborations in the AI field, including combinatorial optimization and machine learning, in May 2017. Fujitsu and 1QBit Collaborate on Quantum Inspired AI Cloud Service (press release, May 16, 2017)

About Fujitsu Laboratories

Founded in 1968 as a wholly owned subsidiary of Fujitsu Limited, Fujitsu Laboratories Ltd. is one of the premier research centers in the world. With a global network of laboratories in Japan, China, the United States and Europe, the organization conducts a wide range of basic and applied research in the areas of Next-generation Services, Computer Servers, Networks, Electronic Devices and Advanced Materials. For more information, please see: http://www.fujitsu.com/jp/group/labs/en/.

About Fujitsu Ltd

Fujitsu is the leading Japanese information and communication technology (ICT) company, offering a full range of technology products, solutions, and services. Approximately 155,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.5 trillion yen (US$40 billion) for the fiscal year ended March 31, 2017. For more information, please see http://www.fujitsu.com.

* Please see this press release, with images, at:
http://www.fujitsu.com/global/about/resources/news/press-releases/

Contact:
Fujitsu Limited
Public and Investor Relations
Tel: +81-3-6252-2176
URL: www.fujitsu.com/global/news/contacts/

↧

Fifth HKTDC Lifestyle Expo in Dubai Opens Monday

September 19, 2017, 9:30 pm

≫ Next: Around 95 State-Owned Enterprises to take part in IBDExpo 2017

≪ Previous: Fujitsu Technology Facilitates Application of Combinatorial Optimization Methods to Real-World Problems

Exhibition and Events to Promote Hong Kong-UAE Cooperation

HONG KONG, Sep 20, 2017 - (ACN Newswire) - The fifth Lifestyle Expo in Dubai will take place from 25-26 September at the Hyatt Regency Dubai, connecting Hong Kong and Chinese mainland suppliers with buyers from the Middle East and Africa to fill the region's growing demand for trendy consumer products.

Jointly organised by the Hong Kong Trade Development Council (HKTDC) and the Trade Development Bureau of the Ministry of Commerce of the People's Republic of China, the Expo will showcase a wide range of stylish, quality items from about 110 Hong Kong and mainland exhibitors. Offerings include consumer electronics, information and communications technology (ICT) products, household products and electrical appliances, fashion and fashion accessories, gifts and premiums, as well as watches and clocks.

About 1,300 importers, distributors, mass retailers, mail-order houses, department stores and specialty stores from the United Arab Emirates (UAE), Iran and Africa are expected to attend the event. Lifestyle Expo in Dubai will also feature business-matching and networking events as well as seminars.

Highlighting Hong Kong's position as Asia's lifestyle trendsetter, the Lifestyle Expo is among the HKTDC's signature international promotion events with a successful track record in fostering trade between companies from Hong Kong and emerging markets worldwide, including Russia, Poland, Turkey, India and Indonesia.

Hub-to-hub strategy

"Hong Kong and the UAE are both hubs for key markets - Asia, and the Middle East and Africa region, respectively," said HKTDC Regional Director for Middle East and Africa Perry Fung at a press conference yesterday.

"Lifestyle Expo provides the perfect setting for realising the hub-to-hub synergy and potential business opportunities that exist between the UAE and Hong Kong," he added.

The third Hub-to-Hub Business Meeting will be held during the Expo to connect exhibitors from Hong Kong and the mainland with Middle East and African buyers for business collaboration. The HKTDC Frequent Buyer Awards 2017 will also be presented during the Expo.

Sourcing opportunities

Buyers from the Middle East and Africa can take advantage of customised one-to-one business-matching services available at the Expo to connect with exhibitors from Hong Kong and the mainland.

Products from about 11 exhibitors will be spotlighted at the hktdc.com Small Orders showcase, where buyers can place orders of between five and 1,000 pieces.

Belt and Road opportunities

The Lifestyle Expo in Dubai will also highlight the enormous business opportunities emerging from China's Belt and Road Initiative, which aims to connect markets spanning Asia, the Middle East, Africa and Europe. With strategic locations and sophisticated economies, both Hong Kong and the UAE are well-positioned to benefit from the Initiative.

"The HKTDC is committed to exploring business opportunities in the Middle East for Hong Kong SMEs while helping those from the Middle East and Africa to expand their business in Asia through the Hong Kong platform," said Mr Fung.

Reinforcing Hong Kong-UAE trade links

The UAE is Hong Kong's largest export market in the Middle East, and trade between the two economies presents an excellent opportunity to build new B2B (business-to-business) links along the Belt and Road.

Hong Kong's exports to the UAE grew 13 per cent to US$6.8 billion last year, led by exports of pearls, precious and semi-precious stones (40.6% of total, up 32.1%), telecom equipment and parts (32.3% of total, up 23.8%), and jewellery (5% of total, up 36.5%).

Fair Website:
Lifestyle Expo in Dubai: http://www.hktdc.com/fair/hkledubai-en

About HKTDC

Established in 1966, the Hong Kong Trade Development Council (HKTDC) is a statutory body dedicated to creating opportunities for Hong Kong's businesses. With more than 40 offices globally, including 13 on the Chinese mainland, the HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. With 50 years of experience, the HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing information via trade publications, research reports and digital channels including the media room. For more information, please visit: www.hktdc.com/aboutus. Follow us on Google+, Twitter @hktdc, LinkedIn.
- Google+: https://plus.google.com/+hktdc
- Twitter: http://www.twitter.com/hktdc
- LinkedIn: http://www.linkedin.com/company/hong-kong-trade-development-council

Contact:
HKTDC
Communication and Public Affairs Department
(Dubai)
Sarah Al Jundi
Tel: +971 4 3298975
Email: sarah.al.jundi@hktdc.org 

(Hong Kong)
Joe Kainz
Tel: +852 2584 4216
Email: joe.kainz@hktdc.org

↧

Around 95 State-Owned Enterprises to take part in IBDExpo 2017

September 19, 2017, 10:43 pm

≫ Next: Maximizing depression treatments with behavioural therapy

≪ Previous: Fifth HKTDC Lifestyle Expo in Dubai Opens Monday

JAKARTA, Sep 20, 2017 - (ACN Newswire) - The Indonesian Ministry of State-Owned Enterprise (MSOEs) is again presenting the Indonesia Business and Development Expo - IBDExpo 2017. Held at Jakarta Convention Center, Sept 20 - 23, the largest SOE exhibition in the country will be joined by 95 Indonesian SOEs and regionally-owned enterprises as well as a number of Singaporean enterprises, incorporated in the Singapore Business Federation, a Singaporean business community focusing on trade, investment, and industry.

Beneath the theme of "Synergy to Make Indonesia Great", this year's event is again organized by the National Publishing and News Corporation (NPNC), a consortium of four media-focused SOEs consisting of Antara News Agency, Balai Pustaka, National Publishing of Indonesia (PNRI) and Peruri.

According to Devi W. Suradji, Special Staff for Communications and Media of the Minister for SOEs, IBDExpo 2017 is designed to display the enormous progress made by the SOEs in shoring up the country's economy and promoting the national growth and public welfare. "This progress does not only refer to technological and infrastructural innovation, but also to innovation and achievement that promote the people's economy, a far-reaching economic contribution," Devi said.

Currently, the total assets of all state-owned enterprises are valued at Rp5,395 trillion with income of Rp1,728 trillion, annual tax contributions at Rp220 trillion and total annual dividend of Rp38 trillion. Capital spending by the state-owned companies in 2017 rose to Rp555 trillion - to finance development of 52 toll roads, 17 airports, 13 seaports, 19 rail tracks and other infrastructure.

Chairman of IBDExpo 2017 Hempi N. Prajudi said that this annual event is designed to enable all participating SOEs to showcase their innovations and achievements and have opportunity to interact directly with visitors. "Through this event, we encourage all of the SOEs to have direct interaction with the public; to hear their aspirations and even their complaints," said Hempi, who is also Commercial Director of Antara, Indonesia's national news agency.

Open for public and free of charge, the IBDExpo 2017 will also feature a number of flagship products and innovations from SOEs, such as a Mobile Shooting Range and military vehicles provided by PT Pindad; flight simulator and a mockup of N219 airplane by PT Dirgantara Indonesia; virtual reality technology by PT Telkom; and many more.

In addition to the exhibition segment, IBDExpo 2017 will also feature a number of side events such as thematic press conferences, which will feature SOE achievements in supporting the implementation of President Joko Widodo's Nawacita (nine ideals) vision. Speaking at the "CEO BICARA", leaders of the SOEs will talk about strategic development in the country such as the program of sea toll, the single price oil fuel program across the country, creative houses of state-owned enterprises for the SMEs, railway transport and food security.

Throughout the exhibition, the synergy between various SOEs, marked by the success of projects such as the development of the sea toll, Jakarta-Bandung high speed train and single price oil fuel program will also be on display. 25 SOEs are also offering jobs in various sectors, there will be a seminar on business opportunities, and a forum of business discussions between leaders of SOEs and private companies.

The IBDExpo 2017 is scheduled to be inaugurated by President Joko Widodo with the attendance of a number of cabinet members, legislators, ambassadors, and C-suite invitees.

About IBDExpo

The Indonesia Business & Development Expo (IBDexpo), with the support of the Ministry of State Owned Enterprises, Republic of Indonesia, related ministries and business associations, takes place Sept 20-21 in Jakarta. IBDexpo showcases the work of State Owned Enterprises and exhibits a wide range of products, investment opportunities and projects, attracting investment promotion agencies and traders from the Asia Pacific region, facilitating two-way trading & investment and the fusion of international capital and projects.

IBDexpo offers optimum opportunities for business people at Asia Pacific region to get an overview on the trade & investment climates in Indonesia. It also provides them with the one-stop shopping service for multilateral investment cooperation, helping them to select from the widest range of investment projects and business partners. For more information, please visit www.ibdexpo.com.

With the support of:
Ministry of State Owned Enterprise,
Republic of Indonesia. www.bumn.go.id.

Organized by the NPNC,
National Publishing & News Corporation.
E: info@ibdexpo.com, T: +62 21 530 3111

NPNC members:
Perum LKBN ANTARA, www.antaranews.com/en.
PT. Balai Pustaka (Persero), www.balaipustaka.co.id.
Perum Percetakan Negara Republik Indonesia, www.pnri.co.id.
Perum Produksi Film Nasional, www.pfn.co.id/id.

↧

Maximizing depression treatments with behavioural therapy

September 19, 2017, 11:00 pm

≫ Next: Mitsubishi Motors @ 45th Tokyo Motor Show an Ambition to Explore

≪ Previous: Around 95 State-Owned Enterprises to take part in IBDExpo 2017

The research suggests that Malaysian health officials should consider providing cognitive behavioural therapy (CBT) in a group setting as a supplement to drug-centred therapy. (Copyright: Cathy Yeulet via 123rf)

Cognitive behavioural therapy enhances effects of anti-depressant drugs in Malaysia

Selangor, Malaysia, Sep 20, 2017 - (ACN Newswire) - Augmenting conventional, pharmaceutical-based treatment of depression with cognitive behavioural therapy reduces depressive symptoms of Malaysians more over a shorter period of time than other treatment methods, according to a study in the journal Social Sciences and Humanities.

Cognitive behavioural therapy (CBT) is a form of "talk therapy" designed to give patients the skills to identify and interrupt patterns of negative thinking and reflexive behaviours that may contribute to mental health problems.

A team of researchers from Universiti Putra Malaysia, Universiti Kebangsaan Malaysia, and the University of Queensland in Australia analysed the effect of CBT on Malaysians. They found that patients treated with CBT along with medication showed greater improvement in a shorter amount of time than other treatment groups.

The research suggests that Malaysian health officials should consider providing CBT in a group setting as a supplement to drug-centred therapy. This would help maximize potential benefits in the face of limited mental healthcare budgets.

"Our findings have important implications for how depression is treated in Malaysia," said lead researcher Low Jia Liang. "It's possible that using CBT in conjunction with pharmacotherapy could bring about significant improvements more quickly, and thereby maximize the impact of constrained health care resources."

As in the rest of the world, depression is a major health concern in Malaysia. The World Health Organization estimates 350 million people suffer from the mood disorder. Within Malaysia, the Institute of Public Health reports that 2.3 million people are at risk for depression within their lifetimes, while other research pegs the incidence of depression in parts of the country as high as 10.3 percent.

Numerous international studies have indicated that CBT can provide effective treatment for depression. However, almost all of those studies have been conducted in Western countries. That raises concerns that cultural differences -- for example, the difference between the "individualistic" nature of Western societies versus the "collectivist" outlook in Asia -- may make CBT less effective for Asian patients.

To design a robust study for Malaysia, the researchers made sure participants reflected the diverse ethnic composition of the country. Participants were divided into three groups: a third received CBT and treatment with anti-depressants; another third were treated solely with anti-depressants; and the final cohort received "relaxation therapy," where they learned physical and mental relaxation techniques, alongside anti-depressants.

Patients in the group treated with CBT along with medication fared better than the other two groups. "What this tells us," said Low Jia Liang, "is that the conventional wisdom about the effectiveness of CBT holds true in the Malaysian context."

For more information on this research, contact:
Low Jia Liang
Universiti Putra Malaysia
Email: joel.law85@gmail.com
The original paper is available at: http://bit.ly/2fiIqZZ

About Pertanika Journal of Social Sciences & Humanities (JSSH)
Pertanika Journal of Social Sciences & Humanities (JSSH) is published by Universiti Putra Malaysia in English and is open to authors around the world regardless of nationality. It is published four times a year in March, June, September and December. Other Pertanika series include Pertanika Journal of Tropical Agricultural Science (JTAS), and Pertanika Journal of Science & Technology (JST).

JSSH aims to develop as a pioneer journal for the social sciences with a focus on emerging issues pertaining to the social and behavioural sciences as well as the humanities. Areas relevant to the scope of the journal include Social Sciences -- Accounting, anthropology, Archaeology and history, Architecture and habitat, Consumer and family economics, Economics, Education, Finance, Geography, Law, Management studies, Media and communication studies, Political sciences and public policy, Population studies, Psychology, Sociology, Technology management, Tourism; Humanities -- Arts and culture, Dance, Historical and civilisation studies, Language and Linguistics, Literature, Music, Philosophy, Religious studies, Sports.

The journal publishes original academic articles dealing with research on issues of worldwide relevance. The journals cater for scientists, professors, researchers, post-docs, scholars and students who wish to promote and communicate advances in the fields of Social Sciences & Humanities research. www.pertanika.upm.edu.my

For more information about the journal, contact:
The Chief Executive Editor (UPM Journals)
Head, Journal Division, UPM Press
Office of the Deputy Vice Chancellor (R&I)
IDEA Tower 2, UPM-MDTC Technology Centre
Universiti Putra Malaysia, Selangor, Malaysia
Phone: +603 8947 1622, Email: nayan@upm.my

Distributed for Pertanika Journal of Science & Technology by ResearchSEA.

↧

Mitsubishi Motors @ 45th Tokyo Motor Show an Ambition to Explore

September 19, 2017, 11:03 pm

≫ Next: Hitachi Introduces Hitachi Vantara: A New Digital Company Committed to Solving the World's Toughest Business and Societal Challenges

≪ Previous: Maximizing depression treatments with behavioural therapy

TOKYO, Sep 20, 2017 - (JCN Newswire) - The 45th Tokyo Motor Show(1) will be like no other before for Mitsubishi Motors - a true milestone event where the corporation will wave the flag under new circumstances to usher a new era of long term growth and sustainable development, returning to where it belongs to better embrace the future.

A beacon for this renewed ambition will be the world premiere of an all-new flagship concept car, the MITSUBISHI e-EVOLUTION CONCEPT.

This very high performance automobile will blend Mitsubishi Motors' signature 4WD and electric powertrain know-how with advanced Artificial Intelligence technology under a low slung aerodynamic SUV Coupe shape.

(1) The 45th Tokyo Motor Show 2017 will be open to the public from October 27th through November 5th with press days on October 25th and 26th, 2017 at Tokyo Big Sight exhibition center.

For more information: http://www.tokyo-motorshow.com/en

About Mitsubishi Motors

Mitsubishi Motors Corporation is the fifth largest automaker in Japan and the fifteenth largest in the world by global unit sales. It is part of the Mitsubishi keiretsu, formerly the biggest industrial group in Japan, and was formed in 1970 from the automotive division of Mitsubishi Heavy Industries.

Throughout its history it has courted alliances with foreign partners, a strategy pioneered by their first president Tomio Kubo to encourage expansion, and continued by his successors. A significant stake was sold to Chrysler Corporation in 1971 which it held for 22 years, while DaimlerChrysler was a controlling shareholder between 2000 and 2005. Long term joint manufacturing and technology licencing deals with the Hyundai Motor Company in South Korea and Proton in Malaysia were also forged, while in Europe the company co-owned the largest automobile manufacturing plant in the Netherlands with Volvo for ten years in the 1990s, before taking sole ownership in 2001.

Contact:
Mitsubishi Motors
Public Relations Department
http://www.mitsubishi-motors.com 
+81-3-6852-4275

↧

Hitachi Introduces Hitachi Vantara: A New Digital Company Committed to Solving the World's Toughest Business and Societal Challenges

September 19, 2017, 11:26 pm

≫ Next: Hitachi Aims To Disrupt Industrial IoT Platform Market With New Commercial Lumada Software Stack

≪ Previous: Mitsubishi Motors @ 45th Tokyo Motor Show an Ambition to Explore

Company Formed to Help Customers Achieve Unprecedented Outcomes by Tapping the Full Potential of Their Data

TOKYO, Sep 20, 2017 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) today launched Hitachi Vantara, a new business entity to leverage the broad portfolio of innovation, development and experience from across Hitachi Group companies to deliver data-driven solutions for commercial and industrial enterprises. This new company will unify the operations of Hitachi Data Systems, Hitachi Insight Group, and Pentaho into a single integrated business as Hitachi Vantara to capitalize on Hitachi's social innovation capability in both operational technologies (OT) and information technologies (IT).

More Than a Century of OT Expertise Combined with IT Trusted by the World's Largest Enterprises

Hitachi has been a leader in OT for industries such as finance, government, manufacturing, power/energy and transportation for over 100 years, providing solutions that have positively impacted cities, industrial operations and businesses at large. The company has also been a leader in IT for over 50 years-bringing IT applications, analytics, content, cloud, and infrastructure solutions to market that have transformed the way enterprises do business. Combining Hitachi's broad expertise in OT with its proven IT product innovations and solutions, Hitachi Vantara gives customers a powerful, collaborative partner in data - unavailable in any one company until today.

"Hitachi Vantara marks a monumental change for Hitachi as we continue to advance our unified corporate vision of Social Innovation," said Hitachi, Ltd. President and CEO Toshiaki Higashihara. "Hitachi has been helping customers harness the power of their data to support meaningful business action for years. Now as the world is being transformed by digital tools and processes, we are unifying our strongest digital solutions companies together as a new Hitachi company that delivers exponential business impact for our customers and the betterment of society. The formation of Hitachi Vantara underscores Hitachi's commitment to collaborative creation with customers and partners, and being a true innovation partner for the era of IoT."

The Opportunity in Data

Hitachi Vantara is uniquely able to help customers extract all the value their data has to offer. By bringing new data-driven solutions and services to market, Hitachi Vantara will help its customers achieve tangible outcomes that positively drive business and society forward.

The market opportunity for mission-critical data solutions has never been greater. Data has become a businesses' greatest asset-if they can extract actionable insights from it. Data holds the key to new revenue streams, better customer experiences, improved market insights and lower costs of doing business. However, a comprehensive offering has yet to emerge that combines both OT and IT expertise to uncover its true potential-until now.

Filling a Critical Gap in the Emerging IoT Market

Hitachi Vantara will continue to provide superior infrastructure and analytics technologies that enterprises rely on for their mission-critical data in their data centers, in the cloud and at the edge of new innovations. The new company is targeting the emerging IoT market opportunity, in which there is no clear winner yet.

According to Gartner, Inc., "more than $440 billion will be spent on IoT in 2020,"(1) and the firm estimates that by 2020, "there will be more than 21 billion connected sensors and endpoints, and digital twins will exist for potentially billions of things."(2) in the same timeframe. To address this market, Hitachi Vantara will harness business, human and machine data across OT and IT environments to build comprehensive, data-driven solutions. Customers will be able to manage, store, govern, blend, analyze, and visualize data-and then take action based on uncovered insights.

Hitachi Vantara's Breadth of Solutions: From the Data Center to the Factory Floor

Hitachi Vantara will continue to develop the trusted data management and analytics technologies Hitachi is known for, including Hitachi's popular data infrastructure, storage and compute solutions, and Pentaho software. It will also be driving the development of strategic software and services solutions, including Hitachi Smart Data Center software and services, Lumada, Hitachi's IoT platform, now available as a standalone, commercial software offering, and Hitachi co-creation services. Announced concurrently today and now in its 2.0 release, Lumada has been fully updated with enhanced artificial intelligence (AI), machine learning and advanced analytics capabilities. It also has an elegant, portable architecture that enables it to run both on-premises or in the cloud, and supports industrial IoT deployments both at the edge and in the core.

The company will focus on serving global Fortune 1000 companies with best-in-class data management, infrastructure, content and analytics products and industrial IoT solutions for a number of industries including financial services and insurance, government, industrials/manufacturing, telecom, and transportation.

"No other company brings together more than a century of operational technology expertise with informational technology trusted in the world's most demanding enterprise environments," said Hitachi Vantara CEO, Ryuichi Otsuki. "Hitachi Vantara capitalizes on this unique combination by creating solutions that meet the needs of an increasingly connected world. Like our customers with whom we partner and co-create, Hitachi Vantara sees data as an opportunity-a path to outcomes that matter."

Hitachi's new Lumada IoT platform and Smart Data Center solutions will be on display at the Hitachi NEXT 2017 user conference in Las Vegas, September 19 and 20, where event attendees can see live demonstrations of the company's software and IoT solutions. For more information, visit HitachiNEXT.com.

(1) Gartner, IoT's Challenges and Opportunities in 2017: A Gartner Trend Insight Report, April 2017 - Mark Hung,
(2) Gartner, Top 10 Strategic Technology Trends for 2017, October 2016 - David W. Cearley, Mike J. Walker and Brian Burke.

About Hitachi Vantara

Hitachi Vantara, a wholly owned subsidiary of Hitachi, Ltd., helps data-driven leaders find and use the value in their data to innovate intelligently and reach outcomes that matter for business and society. We combine technology, intellectual property and industry knowledge to deliver data-managing solutions that help enterprises improve their customers' experiences, develop new revenue streams, and lower the costs of business. Only Hitachi Vantara elevates your innovation advantage by combining deep information technology (IT), operational technology (OT) and domain expertise. We work with organizations everywhere to drive data to meaningful outcomes. Visit us at www.HitachiVantara.com.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges with our talented team and proven experience in global markets. The company's consolidated revenues for fiscal 2014 (ended March 31, 2015) totaled 9,761 billion yen ($81.3 billion). Hitachi is focusing more than ever on the Social Innovation Business, which includes power & infrastructure systems, information & telecommunication systems, construction machinery, high functional materials & components, automotive systems, healthcare and others. For more information on Hitachi, please visit the company's website at www.hitachi.com.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111

↧

Hitachi Aims To Disrupt Industrial IoT Platform Market With New Commercial Lumada Software Stack

September 20, 2017, 12:04 am

≫ Next: Fujitsu Chosen for the Dow Jones Sustainability World Index for 18th Time

≪ Previous: Hitachi Introduces Hitachi Vantara: A New Digital Company Committed to Solving the World's Toughest Business and Societal Challenges

Fully Enhanced and Now Available as a Standalone Offering for IoT Developers and Architects, Hitachi's Lumada Provides an Intelligent, Composable Platform That Delivers Faster Time to Insight and Business Value for Industrial and Enterprise Customers

TOKYO, Sep 20, 2017 - (JCN Newswire) - Hitachi Ltd. (TSE:6501) and Hitachi Vantara, today jointly announced Hitachi's first commercial Lumada internet of things (IoT) platform offering. Now in its v2.0 release, the Lumada IoT platform has been fully updated with an elegant, portable architecture that enables it to run both on-premises or in the cloud and to support industrial IoT deployments both at the edge and in the core.

The new software stack is designed to help customers quickly and easily gain insights, predictions and recommendations from their data, and can be easily adapted to support mid-to-large-scale environments. Lumada's integrated advanced analytics have also been enhanced with artificial intelligence (AI) functionality at scale. The result is a highly intelligent and flexible platform that accelerates superior outcomes for enterprise and industrial customers, such as increased operational efficiencies and cost savings, enhanced operational safety and reliability, improved asset utilization, performance management and product quality, and the creation of new business models.

Among the notable advancements to the Lumada IoT platform are asset avatars, Hitachi's unique approach to what is commonly referred to as "digital twins." Asset avatars provide a digital representation of physical assets and rich metadata for analytics, serving as a digital proxy for business and industrial assets and providing rapid data-driven insights into their health and performance, with continuously updated sensor values. This approach helps to eliminate "blind spots" in operation-critical systems by providing improved access to - and insights from - business, machine and human data, which can help users move more rapidly from measurement to management to improvement. The newly enhanced software stack also provides IoT developers and architects with powerful design tools and features that simplify the creation and deployment industrial IoT solutions, with faster time to insight.

Since introducing Lumada to the market as a co-creation platform in May 2016, Hitachi has hardened and optimized its Lumada IoT platform. These improvements are based on numerous deployments in proof-of concept (POC) and co-creation project engagements with its customers and partners, as well as in its own factories.

Hitachi worked with customer Daicel Corporation to co-create an image analysis system using Lumada that improves product quality and increases productivity by detecting signs of facility failures and deviations in front-line worker motions. This system has allowed Daicel to improve the in-process guarantee rate for products.

Another customer, Okuma Corporation, worked with Hitachi to co-create an advanced high-efficiency production model with Hitachi to support mass customization in its manufacturing plants. The target of this joint demonstration experiment is to double productivity and reduce production lead time by 50%.

Based on the best practices developed throughout projects like these, Hitachi has enhanced Lumada's functionality to simplify management of business and industrial assets, support greater asset utilization and accelerate the time to value of IoT deloyments. Its next generation architecture is highly flexible, composable and adaptable to support customers' existing business and IT environments and help them to more rapidly achieve highly optimized outcomes.

Customers looking to accelerate their IoT initiatives using Lumada will benefit from engaging Hitachi's co-creation services, tapping its expansive expertise in both operation technology (OT) and information technology (IT) to create customized IoT solutions that are tailored to their unique requirements.

"Our next-generation Lumada IoT platform demonstrates Hitachi's unparalleled expertise in both OT and IT, and reinforces Hitachi's commitment to being an innovation partner for our customers in the IoT era," said Keiji Kojima, chairman at Hitachi Vantara and senior vice-president and exective officer at Hitachi Ltd. "With the powerful advancements delivered today, our customers and partners can now choose to harness the full power of Lumada's AI, advanced analytics and asset avatars capabilities to simplify their own IoT solution development or to accelerate their digital transformation initiatives in co-creation projects with Hitachi. In either case, we believe Hitachi is delivering a highly intelligent and unique solution that challenges the industrial IoT platform market status quo."

Hitachi's next-generation Lumada IoT platform architecture has been fully updated with five major layers to form a flexible, portable and composable software foundation with comprehensive security capabilities and expanded support for unstructured data uploads. IoT developers and architects will also benefit from Lumada's dynamic design features, rich analytics and robust asset management capabilities, including:

- Lumada edge: Allows any variety and velocity of data to be easily ingested, transformed and analyzed in close proximity to physical assets.
- Lumada core: Provides asset registry, identity and access management and simplifies the creation of asset avatars.
- Lumada analytics: Blends OT and IT data to uncover patterns with powerful analytics, machine learning and AI.
- Lumada studio: Delivers predefined widgets to simplify the creation of dashboard applications; issues alerts, notifications or just straight-through processing.
- Lumada foundry: Offers foundational services to ease deployment on-premises and in the cloud, as well as security, microservices and support features.

"We are exceedingly proud of the next-generation Lumada software stack we are delivering to the market and opening up to developers today," said Rich Rogers, senior vice-president of engineering and product management at Hitachi Vantara. "However, Hitachi's intention is that Lumada will be much more than just another IoT platform in a crowded market. Lumada's ultimate purpose is to make it simple to harness the power of IoT data to drive real value for Hitachi's customers and partners. We remain committed to delivering exceptional integrated software, solutions and services for Lumada. Our vision is that one day all Hitachi machines will be connected to it, enriching the data-driven insights and value we can provide to ensure every Hitachi customer will benefit."

Product Availability and Information

Hitachi's Lumada IoT platform software is generally available now for purchase and in co-creation engagements with Hitachi and select partners. Some features may not be immediately available in all markets. For more information and a complete list of product and feature enhancements, visit https://www.hitachivantara.com/en-us/products/internet-of-things/lumada.html.

Experience Hitachi's Lumada IoT Platform at NEXT 2017

Hitachi's new Lumada IoT platform software and related solutions will be on display at the company's user conference, Hitachi NEXT, in Las Vegas, September 19 and 20, 2017. Event attendees can see live demonstrations of the software and the innovative IoT solutions Hitachi and its customers and partners are developing with it.

The event also features a full track of IoT developer breakout sessions, providing attendees with an opportunity to engage directly with Hitachi product management executives and development teams. The developer breakout session will provide a deep dive on the latest architectural advancements, design features and best practices for building industrial and commercial enterprise IoT solutions with Lumada. For more information, visit www.hitachinext.com.

About Hitachi Vantara

Hitachi Vantara, a wholly owned subsidiary of Hitachi, Ltd., helps data-driven leaders find and use the value in their data to innovate intelligently and reach outcomes that matter for business and society. We combine technology, intellectual property and industry knowledge to deliver data-managing solutions that help enterprises improve their customers' experiences, develop new revenue streams, and lower the costs of business. Only Hitachi Vantara elevates your innovation advantage by combining deep information technology (IT), operational technology (OT) and domain expertise. We work with organizations everywhere to drive data to meaningful outcomes. Visit us at HitachiNewCo.com. Visit us at www.HitachiVantara.com.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges with our talented team and proven experience in global markets. The company's consolidated revenues for fiscal 2014 (ended March 31, 2015) totaled 9,761 billion yen ($81.3 billion). Hitachi is focusing more than ever on the Social Innovation Business, which includes power & infrastructure systems, information & telecommunication systems, construction machinery, high functional materials & components, automotive systems, healthcare and others. For more information on Hitachi, please visit the company's website at www.hitachi.com.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111

↧

Fujitsu Chosen for the Dow Jones Sustainability World Index for 18th Time

September 21, 2017, 3:26 am

≫ Next: NEC Completes Construction of "SKR1M," a 100Gbps Submarine Cable in Malaysia

≪ Previous: Hitachi Aims To Disrupt Industrial IoT Platform Market With New Commercial Lumada Software Stack

TOKYO, Sep 21, 2017 - (JCN Newswire) - Fujitsu today announced that it has been chosen for inclusion in the Dow Jones Sustainability World Index (DJSI World), the world's leading Socially Responsible Investment (SRI)(1) index. This is the 18th time for Fujitsu to have been included in this index since its creation in 1999.

DJSI World is a stock index offered cooperatively by US-based S&P Dow Jones Indices and Switzerland-based RobecoSAM Indices that selects companies for their excellent sustainability, based on an analysis from the perspective of economics, the environment, and society. Annually, 2,500 companies are eligible globally for this designation, and the top 10% of businesses per industry are chosen from the perspective of sustainability. Including Fujitsu, 319 companies were selected for DJSI World in 2017, 32 of which were Japanese companies.

Fujitsu achieved high evaluations in the IT services & Internet Software and Services industry group on the basis of its environmental initiatives, such as "Environmental Policy & Management Systems" and "Environmental Reporting", and its efforts related to the area of society , including its "Corporate Citizenship and Philanthropy" and "Human Rights" initiatives.

Fujitsu will continue to advance business activities from the perspective of the environment, society, and governance (ESG), and as a truly global ICT company, further increase its efforts to contribute to the sustainable development of society and the Earth.

(1) Socially Responsible Investment (SRI)
A method of investing that, in addition to the usual investment on the basis of financial analysis, also values a company's social responsibility and contributions to society, the environment, and corporate governance. http://www.fujitsu.com/global/about/csr/vision/sri/index.html

About Fujitsu Ltd

Fujitsu is the leading Japanese information and communication technology (ICT) company, offering a full range of technology products, solutions, and services. Approximately 155,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.5 trillion yen (US$40 billion) for the fiscal year ended March 31, 2017. For more information, please see http://www.fujitsu.com.

* Please see this press release, with images, at:
http://www.fujitsu.com/global/about/resources/news/press-releases/

Contact:
Fujitsu Limited
Public and Investor Relations
Tel: +81-3-6252-2176
URL: www.fujitsu.com/global/news/contacts/

↧

NEC Completes Construction of "SKR1M," a 100Gbps Submarine Cable in Malaysia

September 21, 2017, 3:40 am

≫ Next: Honda Added to the Dow Jones Sustainability World Index

≪ Previous: Fujitsu Chosen for the Dow Jones Sustainability World Index for 18th Time

SKR1M Route Map

TOKYO, Sep 21, 2017 - (JCN Newswire) - NEC Corporation (TSE: 6701) today announced the completion of the Sistem Kabel Rakyat 1Malaysia (SKR1M) 100 gigabit per second (Gbps) submarine cable linking Peninsular Malaysia with Sabah and Sarawak.

SKR1M was established through a Public-Private Partnership (PPP) collaboration between Telekom Malaysia Berhad (TM) and the Malaysian Government through the Malaysian Communications and Multimedia Commission (MCMC). TT dotCom Sdn Bhd (TTdC), a wholly-owned subsidiary of TIME dotCom Berhad (TIME) also funded and owns a portion of this submarine cable.

SKR1M was built with the objective of enhancing the existing domestic submarine cable connectivity between Peninsular Malaysia, Sabah and Sarawak, thus catering for future bandwidth growth requirements. The new submarine cable system spans over 3,800 kilometers and lands at six landings, namely, Kuantan, Mersing, Kuching, Bintulu, Miri, and Kota Kinabalu. It is upgradable to 12.8 terabits per second (Tbps) of capacity.

Datuk Seri Panglima Dr Mohd Salleh Tun Said Keruak, Minister of Communications and Multimedia Malaysia said, "This new submarine cable system is part of the Government's initiatives via MCMC to increase the capacity of high-speed broadband and data traffic between Peninsular Malaysia and Sabah and Sarawak. This is among the measures which the Government is undertaking to improve the socio-economic status of people in Sabah and Sarawak through ICT adoption and broadband connectivity and was mentioned by our honorable Prime Minister during the tabling of the 2014 budget. Thus, I am delighted that today, this goal has become a reality."

Atsuo Kawamura, Executive Vice President of NEC Corporation said, "NEC has been active in the submarine cable system business for more than 40 years, and in 1980, NEC supplied Malaysia with its first domestic coaxial submarine cable system. NEC has laid a total of more than 250,000 kilometers of cable--the equivalent of six trips around the earth's equator, and we are now recognized as one of the world's top submarine cable vendors. On this occasion, I would like to extend my congratulations to MCMC and TM, and my heart-felt thanks for yet again selecting NEC as your partner to build SKR1M. I sincerely hope that our partnership will be further enhanced, and be given the next opportunity to contribute to the various regions of Malaysia."

http://www.acnnewswire.com/topimg/Low_NECSKR1MRouteMap.jpg
SKR1M Route Map

About NEC Corporation

NEC Corporation is a leader in the integration of IT and network technologies that benefit businesses and people around the world. By providing a combination of products and solutions that cross utilize the company's experience and global resources, NEC's advanced technologies meet the complex and ever-changing needs of its customers. NEC brings more than 100 years of expertise in technological innovation to empower people, businesses and society. For more information, visit NEC at http://www.nec.com.

Based on its Mid-term Management Plan 2015, the NEC Group globally provides "Solutions for Society" that promote the safety, security, efficiency and equality of society. Under the company's corporate message of "Orchestrating a brighter world," NEC aims to help solve a wide range of challenging issues and to create new social value for the changing world of tomorrow. For more information, please visit http://www.nec.com/en/global/about/solutionsforsociety/message.html.

Contact:
NEC 
Seiichiro Toda         
s-toda@cj.jp.nec.com 
+81-3-3798-6511c

↧

Honda Added to the Dow Jones Sustainability World Index

September 20, 2017, 6:34 pm

≫ Next: Remembering Traditions at the Chinatown Mid-Autumn Festival 2017

≪ Previous: NEC Completes Construction of "SKR1M," a 100Gbps Submarine Cable in Malaysia

TOKYO, Sep 21, 2017 - (JCN Newswire) - Honda Motor Co., Ltd. today announced that the company was selected for the first time as a component of the Dow Jones Sustainability World Index (DJSI World). The Dow Jones Sustainability Indices (DJSI) serve as one of the key benchmarks for socially responsible investing(1).

The DJSI are the investment indices developed and offered cooperatively by the U.S.-based S&P Dow Jones Indices and Switzerland-based RobecoSAM who evaluate sustainability of the world's leading companies in terms of economic, environmental and social criteria and select companies that demonstrate overall excellence for the indices.

Based on their annual DJSI review, S&P Dow Jones Indices and RobecoSAM published the components list and Honda was selected as a component of the Dow Jones Sustainability Asia/Pacific Index for three consecutive years. In the review, Honda was also ranked in the top 5 for the global Automobile sector and added to the DJSI World.

Through unique creations and challenges as a mobility company, Honda will continue providing appealing products and services that bring joy to customers and helping to solve various social issues. Thus, Honda will strive to become a company society wants to exist.

(1) Investment strategy which includes criteria for evaluating investees' corporate social responsibility, in addition to conventional financial indicator analysis.

About Honda

Honda Motor Co., Ltd. (TSE:7267/NYSE:HMC/LSE:HNDA) is one of the leading manufacturers of automobiles and power products and the largest manufacture of motorcycles in the world. Honda has always sought to provide genuine satisfaction to people worldwide. The result is more than 120 manufacturing facilities in 30 countries worldwide, producing a wide range of products, including motorcycles, ATVs, generators, marine engines, lawn and garden equipment and automobiles that bring the company into contact with over 19 million customers annually. For more information, please visit http://world.honda.com.

Contact:
Honda
Media Inquiries
corporate_pr@hm.honda.co.jp
+81-3-5412-1512

↧

Remembering Traditions at the Chinatown Mid-Autumn Festival 2017

September 20, 2017, 10:40 pm

≫ Next: O-Net Launches 980nm Uncooled Pump Laser in Small Form Factor TO-Can Package

≪ Previous: Honda Added to the Dow Jones Sustainability World Index

Night shot of the Chinatown Street Light-Up (Photo: Kreta Ayer-Kim Seng Citizens' Consultative Committee)

Chinatown Mid-Autumn Festival 2017 Street Light-Up Centrepiece (Photo: Kreta Ayer-Kim Seng Citizens' Consultative Committee)

- Nostalgic-themed lantern display featuring Singapore's traditional lanterns inspires this year's Street Light-Up
- Family togetherness celebrated at inaugural Mid-Autumn Family Fest

SINGAPORE, Sep 21, 2017 - (ACN Newswire) - This year's Chinatown Mid-Autumn Festival invites local and overseas visitors to immerse themselves in the most well-loved traditions of the annual festival. Themed "Celebrations of our Traditions", this year's festival will bring back the traditional cellophane lanterns, which serves as the inspiration for this year's Street Light-Up; while emphasizing family togetherness with a new event.

During the month-long celebration from 23 September to 19 October, over 1,000 beautiful, handcrafted lanterns will light up the streets of Chinatown each evening in a grand display of lights and colours, an annual highlight that draws local and overseas visitors to Chinatown each year.

The Chinatown Mid-Autumn Festival, organised by the Kreta Ayer-Kim Seng Citizens' Consultative Committee (KA-KS CCC) and supported by the Singapore Tourism Board, will kick off at this Saturday's Official Light-Up and Opening Ceremony graced by Guest-of-Honour, Mdm Halimah Yacob, President of the Republic of Singapore. This year's opening ceremony will take the audience back to 1960s Singapore, and feature a lively showcase of gravity-defying acrobatic stunts and multicultural performances that represent Chinatown's colourful ethnic mix.

Dr Lily Neo, Adviser to Jalan Besar GRC GRO (KRETA AYER - KIM SENG) said: "The Chinatown Festivals play an integral role in preserving and passing on our Chinese traditions and customs. For this year's Mid-Autumn Festival, we hope to evoke fond memories for Singaporeans by recreating Singapore's traditional lanterns popular in the 60s to 80s, and give overseas visitors a wonderful glimpse of our traditional lanterns commonly seen in the past during the Mid-Autumn Festival.

"The Festival is also a time of family togetherness. To enrich our line-up of family-oriented activities, we will be organising the inaugural Mid-Autumn Family Fest @ Chinatown to give families a fun and meaningful way to celebrate the festival together and to pass down their customs and traditions", added Dr Neo.

Oldies but goodies for this year's Street Light-Up

Illuminating the streets of Chinatown from 23 September to 19 October are more than 1,000 lanterns along Eu Tong Sen Street, New Bridge Road and South Bridge Road, all handcrafted for the highly-anticipated Street Light-Up. This year's lantern display is inspired by the traditional cellophane paper lanterns popular in Singapore in the 60s to 80s.

Designed in collaboration with students from the Nanyang Academy of Fine Arts (NAFA), the lanterns are made by expert craftsmen from China and reminiscent of the colourful cellophane paper lanterns of yesteryear, traditionally made by tightly wrapping cellophane paper over a wire frame or bamboo strips into various animal shapes such as rabbits, dragons, roosters and fishes. The theme of family togetherness can also be seen in the lantern displays sets of families placed between Eu Tong Sen Street and New Bridge Road.

Adding to the Street Light-Up will be the creative artworks of nearly 400 children and students who took part in the annual Lantern Painting Competition last Sunday. These will be displayed along Pagoda Street until 19 October 2017. There will also be a special group of lanterns drawn by students and painted by the elderly during the event.

Family togetherness celebrated at inaugural Mid-Autumn Family Fest @ Chinatown

A new event this year is the Mid-Autumn Family Fest @ Chinatown on 24 September 2017, where families and friends can take part in a morning of traditional activities associated with the festival. Held at the Kreta Ayer Community Club, there will be various hands-on activities, such as mooncake-making, tea appreciation, calligraphy writing and lantern painting.

Immerse in festive activities till 19 Oct

Starting from 20 September, local and overseas visitors can look forward to finding a wide array of festive must-haves and treats from mooncakes and tea to preserved fruits and decorative ornaments at the annual Festive Street Bazaar.

For the arts-inclined, the Nightly Stage Shows at Kreta Ayer Square will fill the evening air with song and dance performances by local and overseas troupes and entertainers that will amplify the celebratory mood during the festival.

The Chinatown Mid-Autumn Festival 2017 will draw to a close with the Mass Lantern Walk on 1 October, where up to 5,000 people are expected to come together to mark the Mid-Autumn Festival under a moonlit night, topped with entertaining performances by local clan associations, overseas performing groups and dragon dance troupes.

For more information, please visit us at:
Website: www.chinatownfestivals.sg
Facebook: https://www.facebook.com/chinatown.festivals

Photos from this year's Street Light-Up and last year's Chinatown Mid-Autumn Festival 2016 events can be downloaded from http://bit.ly/2w5NgwA
Please credit all photos to Kreta Ayer-Kim Seng Citizens' Consultative Committee.

If you have any queries, please contact:

Lim Wan Qi
Ninemer Public Relations P L
limwanqi@ninemer.com
+65 6534 9959 | +65 9137 0503

Robyn Chen
Ninemer Public Relations P L
robynchen@ninemer.com
+65 6534 9959 | +65 9728 8858

↧

O-Net Launches 980nm Uncooled Pump Laser in Small Form Factor TO-Can Package

September 21, 2017, 12:28 am

≫ Next: Eisai Presents Latest Non-Clinical Data on Its First Antibody-Drug Conjugate MORAb-202 at 8th Annual World ADC

≪ Previous: Remembering Traditions at the Chinatown Mid-Autumn Festival 2017

Aims at Satisfying Increasing Demand For Coherent Transmission Modules and Compact Optical Amplifier Applications

HONG KONG, Sep 21, 2017 - (ACN Newswire) - O-Net Technologies (Group) Limited ("O-Net" or the "Group") (stock code: 877), a leading high-technology enterprise, is pleased to announce the launch of 980nm uncooled pump laser in small form factor TO-Can package ("TO pump"), a high-power laser for optical amplification applications for coherent transmission modules and compact optical fiber amplifier applications. The product will encourage the transition to the next generation of small form factor compact EDFA which can be incorporated inside the CFP2 ACO / DCO modules and has set a new industry standard. With the launch of the new product, O-Net will start the qualification process with various major customers, and mass production of the TO pump is expected to commence in Q1 2018.

As a pioneer in the provision of high-technology products and solutions, O-Net has continued to further expand from its origin as a supplier of optical networking products. In view of the strong demand for coherent transmission products to support rising bandwidth demand for data center interconnect and metro networks, the Group leverages state-of-art design and manufacturing capability of 3SP Technologies ("3SP") and the TO-Can packaging technology of O-Net to make significant strides in pump laser technology as demonstrated by the development of the TO pump. The TO pump is derived from a 980 nm uncooled pump laser platform for optical amplification which significantly reduces in product size and enables operation in condensed physical environments.

Mr. Austin Na, Chairman and CEO of O-Net, said, "The launch of the TO pump is a testament to our ability to develop the next generation of optical networking products for the data center interconnect market. We expect both passive and active optical networking products will continue to present numerous opportunities, and take the Group's core optical networking business to new heights. With a strong global R&D and manufacturing presence, we will continue to expand our portfolio of high-growth new products in a bid to enlarge the Group's market share and create synergies for our businesses as we access high potential data communication networks."

About O-Net Technologies (Group) Limited (Stock code: 877)
O-Net Technologies (Group) Limited, with headquarter in Shenzhen, was listed on the Stock Exchange of Hong Kong Limited on 29 April 2010. It is a leading supplier of optical networking products to the global optical telecommunications and data-communications markets. To further strengthen the Group's leadership in the global technology industry, O-Net, along with 3SP and ITF, secures the supply of advanced laser chips and optical components in order to widen the Group's product range and improve its technologies through vertical integration. Riding on the Group's core optical networking technology platform, it has diversified from its core business to certain new businesses including automation, sensing and industrials, and has re-positioned its strategic focus from a sole telecom passive component supplier to a high technology leader with advanced products and solutions for cloud data centers, industrial laser, ADAS and consumer electronics markets with an aim to become a leading high-tech company.

Media enquiries:
Strategic Financial Relations Limited
Maggie Au +852 2864 4815 maggie.au@sprg.com.hk
Isabel Kwok +852 2864 4824 isabel.kwok@sprg.com.hk
Nelda Lai +852 2114 4903 nelda.lai@sprg.com.hk
Fax: +852 2527 1196 / 2804 2789

↧

Eisai Presents Latest Non-Clinical Data on Its First Antibody-Drug Conjugate MORAb-202 at 8th Annual World ADC

September 22, 2017, 2:56 am

≫ Next: RTI and NEC Announce that the SEA-US Submarine Cable is Ready for Service and that the Marine Survey has Begun for a Hong Kong Extension

≪ Previous: O-Net Launches 980nm Uncooled Pump Laser in Small Form Factor TO-Can Package

TOKYO, Sep 22, 2017 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest non-clinical data on MORAb-202, Eisai's first antibody-drug conjugate (ADC) developed by its research subsidiary Morphotek, Inc., was presented at the 8th Annual World ADC.(1-2)

MORAb-202 is a new ADC which combines farletuzumab, an investigational anti-folate receptor alpha (FRA) antibody, with a payload* of Eisai's in-house developed anticancer agent eribulin (generic name: eribulin mesylate, product name: Halaven).

The presentation at the 8th Annual World ADC covered the results of non-clinical studies investigating MORAb-202. MORAb-202 demonstrated high selectivity for FRA-positive cancer cells, which are expressed in approximately 60% of triple-negative breast cancer patients, as well as strong antitumor activity. Furthermore, there was a confirmed bystander effect**, with MORAb-202 also exhibiting antitumor activity on the FRA-negative cancer cells surrounding the FRA-positive cancer cells. MORAb-202 showed high selectivity for FRA-positive cancer cells and a long half-life in the blood (111-178 hours), and in mouse models inoculated with cancer, a 60-day tumor regression effect was observed based a single dose using only a fifth of eribulin's clinical dosage.

After MORAb-202 enters the target cancer cells, the linker is enzymatically cleaved, separating eribulin, the payload, from the antibody. The released eribulin then displays its original high antitumor effects. Additionally, ADCs have been known to have high aggregation levels due to the influence of hydrophobic payloads, but since MORAb-202 employs the water-soluble eribulin as a payload, aggregation is under 1%. Due to this characteristic of reaching the cancer cells without aggregating in the blood, MORAb-202 suggests a high safety profile. With its base of Eisai's in-house developed eribulin, MORAb-202 demonstrates new generation ADC characteristics, namely, internalization into target cancer cells, an antitumor effect followed by a bystander effect after its releasing its drug payload, and aggregation inhibition. Eisai plans to move MORAb-202 into the clinical stage during the latter half of FY 2017.

Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. The company will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

* Payload: An anticancer agent connected to an antibody via a linker in an ADC.
** Bystander effect: When the anticancer agent and antibody parts of an ADC are separated inside a targeted antigen-positive cancer cell, the released anticancer agent also affects neighboring antigen-negative cancer cells and the component cells of the cancer microenvironment.

About Morphotek, Inc. and MORAb-202

Morphotek, Inc., a subsidiary of Eisai Inc.in the United States, is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology. Morphotek, Inc. developed MORAb-202, which combines anticancer agent farletuzumab, an IgG1 monoclonal antibody that binds to the folate receptor alpha, and Eisai's in-house developed anticancer agent eribulin using an enzyme cleavable linker. After entering the target cancer cells, the linker is enzymatically cleaved, separating eribulin from the antibody, which is thought to create a therapeutic effect on the cancer cells and surrounding cancer microenvironment. Morphotek, Inc. is currently preparing MORAb-202 for Phase I clinical trials. In non-clinical studies, MORAb-202 demonstrated high target selectivity for FRA-positive cancer cells, strong anticancer activity (50% Inhibitory Concentration (IC50) against FRA-positive cells IC50 = 0.001-23nM, FRA-negative cells IC50 > 100nM), a clear bystander effect in the co-culture of positive and negative FRA-positive cells, long half-life in blood (111-178 hours), and a long-lasting antitumor effect with only a single dose (In mouse models inoculated with triple-negative breast cancer cells and dosed with 5mg/kg, a 60-day tumor regression effect and complete response in 4 out of 8 mice was observed). Additionally, by leveraging the combination of eribulin, with its unique mechanism of action, in-house developed antibodies, and antibody conjugation technology, Morphotek, Inc. launched a new ADC Services business in April 2017.

About farletuzumab (development code: MORAb-003)

Farletuzumab is a humanized, IgG1 monoclonal antibody that binds to the folate receptor alpha (FRA). Farletuzumab is currently undergoing Phase II clinical trials in Japan, the United States and Europe, for the treatment of recurrent platinum-sensitive ovarian cancer with a low CA125 level.

About eribulin (generic name: eribulin mesylate, product name: Halaven)

Eribulin is the first in the halichondrin class of microtubule dynamics inhibitors with a novel mechanism of action. Structurally eribulin is a simplified and synthetically produced version of halichondrin B, a natural product isolated from the marine sponge Halichondria okadai. Eribulin is believed to work by inhibiting the growth phase of microtubule dynamics which prevents cell division. In addition, recent non-clinical studies showed that eribulin is associated with increased vascular perfusion and permeability in tumor cores. Eribulin promotes the epithelial state and decreases the capacity of breast cancer cells to migrate and invade. Eribulin was first approved in November 2010 in the United States as a treatment for patients with metastatic breast cancer who have received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting. Eribulin is currently approved for use in the treatment of breast cancer in over 60 countries worldwide, including Japan and countries in Europe, the Americas and Asia. In Japan, eribulin has been approved to treat inoperable or recurrent breast cancer and was launched in the country in July 2011. In addition, eribulin has been approved in countries in Europe and Asia indicated as a treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting, unless patients were not suitable for these treatments. Regarding soft tissue sarcoma, eribulin was approved in the United States for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen in January 2016, approved in Japan for the treatment of soft tissue sarcoma in February 2016, and approved in Europe for the treatment of adult patients with unresectable liposarcomas who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease in May 2016.

(1) Albone E. "MORAb-202 -- A Potent Human Folate Receptor Alpha-Targeting ADC that Utilizes the Anti-tubulin Agent Eribulin as Payload" Oral Presentation at the 8th Annual World ADC.
(2) Furuuchi K. et al "MORAb-202, a novel antibody-drug conjugates (ADC) comprised of farletuzumab conjugated with eribulin, exhibits long-lasting targeted antitumor activity and payload-mediated bystander effects on the tumor microenvironment." Scientific Poster Session at the 8th Annual World ADC.

About Eisai

Eisai Co., Ltd. (TSE:4523; ADR:ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.

Contact:
Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120

↧

RTI and NEC Announce that the SEA-US Submarine Cable is Ready for Service and that the Marine Survey has Begun for a Hong Kong Extension

September 21, 2017, 7:08 pm

≫ Next: Eisa: Additional Dosage and Administration of Proton Pump Inhibitor Pariet 5 mg Tablets, 10 mg Tablets Approved in Japan for Maintenance Therapy of Proton Pump Inhibitor Resistant Reflux Esophagitis

≪ Previous: Eisai Presents Latest Non-Clinical Data on Its First Antibody-Drug Conjugate MORAb-202 at 8th Annual World ADC

SEA-US Cable Route and HK-G Extension

TOKYO, Sep 22, 2017 - (JCN Newswire) - RAM Telecom International, Inc. (RTI) and NEC Corporation (TSE: 6701) announced today that the Southeast Asia - United States Cable System (SEA-US) is ready for commercial service following acceptance by the SEA-US consortium(1), and that construction has commenced on the Hong Kong - Guam Cable System (HK-G) extension.

The consortium's US $250 million investment in SEA-US delivers an initial design capacity of 20 Terabits per second (Tbps) of capacity, using NEC's state-of-the-art 100 Gigabit per second (Gbps) submarine cable technology. SEA-US's capacity is essential to facilitating exponentially growing demand for bandwidth between Asia and North America. The new cable also greatly enables onward connectivity to existing and planned submarine cable systems, including the recently announced HK-G by RTI's affiliate, RTI Connectivity Pte. Ltd. (RTI-C). NEC is the supplier for the HK-G extension.

http://www.acnnewswire.com/topimg/Low_NECSEAUS.jpg
SEA-US Cable Route and HK-G Extension

RTI-C and NEC also announced today that the marine route survey for HK-G has begun. The detailed information that will be gathered during the survey will shape the final route engineering that will be undertaken. This is a significant development in the construction of the 3,900-kilometer HK-G, which will land in Piti, Guam at the recently completed Teleguam Holdings LLC (GTA) cable landing station, the same facility which is being utilized for SEA-US.

Russ Matulich, RTI's President and CEO, acknowledged this important milestone stating, "Transpacific capacity demand will continue to outweigh existing supply for many years to come, and RTI's SEA-US investment is now providing essential route diversity capabilities and onward connectivity options for our clients." Matulich added, "Initiating the HK-G marine route survey is an important milestone towards our goal of providing fully diverse transpacific connectivity. Once completed, HK-G will seamlessly interconnect with SEA-US, allowing customers to not only diversify their traffic between Hong Kong to Los Angeles, but also enabling them to port their existing capacity to different destinations."

Mr. Toru Kawauchi, General Manager of NEC's Submarine Network Division said, "It is with deep pride that NEC, as one of the world's top vendors of submarine cable systems, has handed over the keys to launch the SEA-US Cable to RTI and the SEA-US consortium members. From the day we signed the contract, we have dedicated our best resources to completing this cable. There are plenty of obstacles for every cable we build, and SEA-US was not immune to this. By working together with the cable owners, we have overcome each-and-every obstacle and look forward to many more years of further enhancing our relationship in order to answer the global demand for connectivity."

NEC has more than 40 years of experience in the submarine cable business and is recognized as one of the world's top submarine system vendors. NEC has laid a total of more than 250,000 kilometers of submarine cable, the equivalent of six trips around the earth. As a total system integrator, NEC produces optical submarine cable, optical submarine repeaters and equipment for connecting optical transmissions to land, in addition to carrying out ocean surveys, route design, laying optical submarine cable and training personnel for the handover of these systems.

(1) The SEA-US consortium includes Globe Telecom (Manila, Philippines), GTA (Tamuning, Guam), GTI (Los Angeles, California), Hawaiian Telcom (Honolulu, Hawaii), RTI (San Francisco, California), Telin (Jakarta, Indonesia), and Telin USA (Los Angeles, California)

About RTI

RTI and its affiliates are leading neutral cable owners and develop global telecom infrastructure and large-scale data connectivity in selected markets. RTI offers its neutral products and services to international telecommunications carriers, multinational enterprises, global content providers and educational institutions. RTI is headquartered in San Francisco, California and RTI-C is headquartered in Singapore. For more information, visit www.rticable.com.

About NEC Corporation

NEC Corporation is a leader in the integration of IT and network technologies that benefit businesses and people around the world. By providing a combination of products and solutions that cross utilize the company's experience and global resources, NEC's advanced technologies meet the complex and ever-changing needs of its customers. NEC brings more than 100 years of expertise in technological innovation to empower people, businesses and society. For more information, visit NEC at http://www.nec.com.

Based on its Mid-term Management Plan 2015, the NEC Group globally provides "Solutions for Society" that promote the safety, security, efficiency and equality of society. Under the company's corporate message of "Orchestrating a brighter world," NEC aims to help solve a wide range of challenging issues and to create new social value for the changing world of tomorrow. For more information, please visit http://www.nec.com/en/global/about/solutionsforsociety/message.html.

Contact:
NEC 
Seiichiro Toda         
s-toda@cj.jp.nec.com 
+81-3-3798-6511

↧

Eisa: Additional Dosage and Administration of Proton Pump Inhibitor Pariet 5 mg Tablets, 10 mg Tablets Approved in Japan for Maintenance Therapy of Proton Pump Inhibitor Resistant Reflux Esophagitis

September 21, 2017, 8:46 pm

≫ Next: Sir David Adjaye Joins Elite Panel of Judges for Lexus Design Award 2018

≪ Previous: RTI and NEC Announce that the SEA-US Submarine Cable is Ready for Service and that the Marine Survey has Begun for a Hong Kong Extension

TOKYO, Sep 22, 2017 - (JCN Newswire) - Eisai Co., Ltd. and Eisai's subsidiary for gastrointestinal disease area EA Pharma Co., Ltd. announced today that Eisai has obtained the approval of additional dosage and administration in Japan of the proton pump inhibitor Pariet 5 mg Tablets and 10 mg Tablets (generic name: rabeprazole sodium) to administer 10 mg of rabeprazole sodium per dose twice-daily for the maintenance therapy of proton pump inhibitor-resistant reflux esophagitis (reflux esophagitis in which it is difficult to achieve satisfactory therapeutic effects by existing treatment with once-daily dosing of proton pump inhibitors). In Japan, Eisai is the marketing and manufacturing authorization holder for Pariet, while EA Pharma is responsible for distribution.

Reflux esophagitis is a condition which causes erosion of the mucosal lining of the esophagus due to the regurgitation of stomach acid and other causes, as well as frequent and persistent symptoms such as heartburn, discomfort in the throat and belching, with repeated recurrence and recrudescence. The prevalence of this condition in Japan is estimated to be 10%.(1) In many cases, 8 weeks of initial treatment followed by maintenance therapy with a once-daily proton pump inhibitor is sufficient to cure reflux esophagitis and prevent remission. However, in approximately 15% of reflux esophagitis cases, these treatments are not enough to achieve satisfactory therapeutic effects.(2) For patients with proton pump inhibitor-resistant reflux esophagitis, Pariet is the only proton pump inhibitor available for treatment by twice-daily dosing at 10 mg or 20 mg each. However, there is an 8 week dosing period limit, and after that, maintenance therapy by once-daily dosing at 10 mg occurs. With the above approval, Pariet becomes the only proton pump inhibitor available for maintenance therapy by twice-daily dosing at 10 mg and is anticipated to further fulfil unmet medical needs.

The above approval was made based on the results of a double-blind controlled Phase III clinical study conducted in Japan, in which the efficacy and safety of twice-daily dosing of Pariet 10 mg Tablets were evaluated against once-daily dosing of Pariet 10 mg Tablets in patients with reflux esophagitis who had inadequate response to existing treatment with proton pump inhibitors. In the primary endpoint of non-recurrence rates as confirmed by endoscopy at 52 weeks of maintenance therapy, the twice-daily dosing group demonstrated a statistically significant improvement over the once-daily group, with non-recurrence rate in the twice-daily dosing group at 73.9% compared to 44.8% in the once-daily group (P
Eisai and EA Pharma consider it their mission as R&D-based pharmaceutical companies in possession of originator drugs to seek new value for long-listed drugs to increase patient benefits. The above approval will add a treatment option for patients with reflux esophagitis who had inadequate response to the existing treatment by proton pump inhibitors, and through this, the two companies aim to further contribute to the treatment of patients with acid-related diseases.

About Pariet

Pariet is a proton pump inhibitor that was discovered and developed by Eisai Co., Ltd. First launched in Japan in 1997, it is approved in more than 100 countries and territories worldwide. In Japan, Pariet is indicated for multiple uses, including for the treatment of gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux esophagitis, Zollinger-Ellison syndrome, non-erosive gastroesophageal reflux disease, the prevention of recurrent gastric or duodenal ulcer caused by low-dose aspirin therapy and as an adjunctive therapy in Helicobacter pylori (H. pylori) eradication, and is available in 5 mg, 10 mg and 20 mg tablet formulations in Japan. In addition, in December 2010, Eisai was granted domestic approval for additional twice-daily 10 mg and twice-daily 20 mg dosage and administration of Pariet for treatment of patients with reflux esophagitis who are unable to obtain satisfactory relief with conventional proton pump inhibitor treatment.

Details of the above approval (The underlined parts are added.)

1) Product Pariet 5 mg Tablets, Pariet 10 mg Tablets
2) Dosage and administration (Extract of the section of reflux esophagitis only)
*The section of reflux esophagitis is divided into the parts of and

Curative Therapy

For treatment of reflux esophagitis, the usual adult dose for oral use is 10 mg of rabeprazole sodium administered once-daily. However, the dosage may be increased up to 20 mg orally once-daily depending on the severity of symptoms. The usual administration should be restricted to up to 8 weeks. For patients who do not achieve satisfactory therapeutic effects by proton pump inhibitors, Pariet can be given orally at a dose of 10 mg or 20 mg twice-daily for additional 8 weeks. The dosing at 20 mg twice-daily, however, should be limited to those patients who have severe mucosal injury.

Maintenance Therapy

For the maintenance therapy of reflux esophagitis showing repeated recurrence and recrudescence, the usual adult dose for oral use is 10 mg of rabeprazole sodium once-daily. For the maintenance therapy of reflux esophagitis in patients who do not achieve satisfactory therapeutic effects by proton pump inhibitors, Pariet can be given orally at a dose of 10 mg twice-daily.

About usage of Pariet for reflux esophagitis
http://www.acnnewswire.com/topimg/Low_EisaiRefluxEsophagitis.jpg

About EA Pharma

EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd. for gastrointestinal disease area, was established in April 2016 by integration of the gastrointestinal business unit with at least 60 years history of the Eisai Group and the gastrointestinal business unit of the Ajinomoto Group having amino acid as its business core. EA Pharma is a gastrointestinal specialty pharma with a full value chain covering R&D, logistics and sales & marketing. For more information on EA Pharma Co., Ltd., please see https://www.eapharma.co.jp/en/

(1) Japanese Society of Gastroenterology, GERD Diagnosis Guidelines, 2015 (2nd Revised Edition)
(2) Chiba N., et al, Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis, Gastroenterology. 1997;112(6):1798-810.

About Eisai

Eisai Co., Ltd. (TSE:4523; ADR:ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.

Contact:
Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120

↧

Sir David Adjaye Joins Elite Panel of Judges for Lexus Design Award 2018

September 21, 2017, 9:33 pm

≫ Next: Showa Denko Establishes Fourth Bulk Molding Compound Plant in Asia

≪ Previous: Eisa: Additional Dosage and Administration of Proton Pump Inhibitor Pariet 5 mg Tablets, 10 mg Tablets Approved in Japan for Maintenance Therapy of Proton Pump Inhibitor Resistant Reflux Esophagitis

Toyota City, Japan, Sep 22, 2017 - (JCN Newswire) - Lexus is excited to announce the addition of visionary architect Sir David Adjaye as the newest judge for Lexus Design Award 2018. Adjaye, one of the most influential architects of his generation, complements an already world-class panel of judges that also recently added innovative architect Shigeru Ban. Through the Lexus Design Award, Sir David Adjaye and other judges will identify and recognize the next wave of global creators and designers.

Each year, thousands of young creative talent from around the world aspire to be selected to participate in Lexus Design Award, where they have an opportunity to receive mentorship from established global designers, prototype funding, and an invitation to exhibit at the Lexus Design Event during Milan Design Week. Sir David Adjaye and the other judges will select the 12 finalists that best embody this year's theme, "CO-" and reflect the Lexus brand belief that great design can make the world a better place. At Milan Design Week 2018, Adjaye and his fellow judges will award the coveted grand prix award to one of the finalists.

"The Lexus Design Award provides an incredible platform for young designers from around the globe to help craft a more inclusive future. I'm honored to be part of this panel helping to elevate these voices. This year's theme particularly resonated with me. As we negotiate the challenges of the 21st century, thinking collaboratively and across disciplines is more important than ever before." - Sir David Adjaye.

Named as one of the world's 100 Most Influential People by Time Magazine, the Ghanaian-British architect was knighted in 2017 for services to architecture. In 2016, he received the Panerai London Design Medal. Among his recent accomplishments, Sir Adjaye, designed the National Museum of African American History and Culture - a Smithsonian Institution museum, on the National Mall in Washington, D.C. - featuring a crown motif from Yoruba (native Nigerian) sculpture.

Entries to the Lexus Design Award 2018 competition are accepted from July 24 through October 08. The 12 finalists will be announced in January 2018 and the Grand Prix winner will be announced during Milan Design Week - April 16th 2018. For more information on Lexus Design Award 2018, see LexusDesignAward.com.

About LEXUS

Since its debut in 1989, Lexus has earned a worldwide reputation for high-quality products and exemplary customer service. Lexus is the hybrid leader among luxury brands, offering hybrids that provide the best in innovative technology and premier luxury. The evolution of Lexus is reflected in the progressive designs of its new vehicles. The grille, dynamic light treatments, and sculptured lines create a distinctive look of luxury for Lexus. For more information, please visit www.lexus-int.com and www.lexus-int.com/news/.

Contact:
Public Affairs Division
Global Communications Department
Toyota Motor Corporation
Tel: +81-3-3817-9926

↧

Showa Denko Establishes Fourth Bulk Molding Compound Plant in Asia

September 21, 2017, 9:00 pm

≫ Next: "Think Asia, Think Hong Kong" Inspires London Audience

≪ Previous: Sir David Adjaye Joins Elite Panel of Judges for Lexus Design Award 2018

Ceremony for the completion of the new plant

SDNZ's new plant

SDNZ Has a Ceremony for the Completion of New Plant in Zhuhai, China

TOKYO, Sep 22, 2017 - (JCN Newswire) - Today, Showa Denko New Material (Zhuhai) Co., Ltd. (SDNZ), a consolidated subsidiary of Showa Denko ("SDK"; TSE:4004), had a ceremony for the completion of its new plant to produce thermosetting bulk molding compound (BMC) in Zhuhai, Guangdong Province, China.

SDNZ's new plant is the Showa Denko Group's second BMC production base in China, while the first one in China is located in Shanghai.

SDK Group's BMC business sector formerly had production bases at three locations, namely, in Japan, Shanghai and Thailand. The production base in Shanghai has been supplying BMC to customers mainly in East China, and has been operating at full capacity because sales of BMC in China have been rapidly increasing, centering on the application for automobiles and home electrical appliances. The new plant of SDNZ, of which we had a ceremony for the completion today, will supply BMC to customers mainly in South China.

Under its ongoing medium-term consolidated business plan, "Project 2020+," SDK Group positions its business in functional chemicals including BMC as "Growth-accelerating" business. SDK Group will make its BMC production system, which comprises four production bases located in Japan, Shanghai, Zhuhai and Thailand, ready to be operated at full capacity as soon as possible, and aggressively expand its functional chemicals business especially in China and ASEAN region where rapid growth of the market is expected.

Outline of the second BMC production base in China

Company name: Showa Denko New Material (Zhuhai) Co., Ltd.
Location: Zhuhai, Guangdong Province, China
Date of incorporation: July 2015
Scope of business: Production of BMC
Capital: RMB 70,000,000 (JPY 1,190,000,000: RMB 1/JPY 17)
Shareholders: SDK (70%), Eternal Materials Co., Ltd. (30%)
Number of employees: about 50 employees

About Showa Denko K.K.

Showa Denko K.K. ("SDK"; TSE:4004, US:SHWDF) is a major manufacturer and marketer of chemical products serving a wide range of fields ranging from heavy industry to the electronic and computer industries. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial and high-performance gases and chemicals and high-purity gases and chemicals for the semiconductor industry, and the Inorganics Sector provides ceramics products such as alumina, abrasive, refractory and graphite electrodes and fine carbon products. Today, the Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high-bright LEDs and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, please visit www.sdk.co.jp/english/.

Contact:
Public Relations Office
Phone: 81-3-5470-3235

↧

Latest Images